David S. Hong, MD | Authors


TRK Inhibitors for Advanced Solid Tumors: Next Steps in Research

March 25, 2021

David S. Hong, MD, of The University of Texas MD Anderson Cancer Center, shares his enthusiasm for ongoing research efforts to optimize treatment for patients with advanced solid tumors who harbor NTRK gene fusions.